FSKLX Mutual Fund

NAV$14.33

Fund Essentials - as of Jan 31, 2026

Net Assets
-
Expense Ratio
0.16%
Dividend Yield (Current)
2.48%
Holdings
141
Inception Date
May 29, 2015
Fund Family
Fidelity Investments (US)
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+4.42%
1 Year+9.12%
3 Year+10.58%
5 Year+5.51%
10 Year+5.78%

Asset Allocation

Stocks: 98.98%
Bonds: 0.04%
Cash: 0.92%
Other: 0.06%

Price Chart (6M)

Loading chart data...

Top Holdings

View All →
TickerNameWeight
ROG:SMRoche(Pharma And Diagnostic Equipment Manufacturer)2.56%
NOVN:SMNovartis Ag Ordinary Shares2.17%
7182:JPJapan Post Bank Co. Ltd. Com Stk2.08%
AZN:LNAstrazeneca Plc Adr2.05%
GSK:LNGSK plc1.95%
Top 10 Concentration: 19.77%Report Date: Jan 31, 2026
Download all 141 holdings for FSKLX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
2.48%
Frequency
Annually
Latest Distribution
$0.28
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
See how FSKLX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
$49$29/mo
Claim the $29 launch price
First 500 subscribers, then $49/mo. Cancel anytime. From MarketXLS, trusted since 2014.

FSKLX Mutual Fund Overview

FSKLX Mutual Fund (Fidelity SAI International Low Volatility Index Fund) is managed by Fidelity Investments (US). FSKLX expense ratio is 0.16%, holding 141 positions across sectors including Unknown, Financials, Industrials. Inception date: 2015-05-29.

FSKLX performance shows a YTD return of 4.42%. The 1-year return is 9.12% and the 5-year return is 5.51%. FSKLX dividend yield stands at 2.48%, paid annually.

FSKLX top holdings include Roche(Pharma And Diagnostic Equipment Manufacturer) (2.6%), Novartis Ag Ordinary Shares (2.2%), Japan Post Bank Co. Ltd. Com Stk (2.1%), Astrazeneca Plc Adr (2.0%), GSK plc (1.9%). View all FSKLX holdings, sector breakdown, or dividend history.

FSKLX can be compared against other funds using the overlap calculator or side-by-side comparison tool. FSKLX alternatives are available via the screener, along with tax-loss harvesting opportunities.